Loading...

Xiao Wei, MD

TitleCLINICAL FELLOW
SchoolUCSF School of Medicine
DepartmentMedicine
Address3333 California Street
San Francisco CA 94104
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCSFMedical Oncology FellowshipHematology/Oncology
    UCSFMaster's Degree Program in Clinical ResearchEpidemiology & Biostatistics
    UCSFPrecision Health Science TL1 (PRESCIENT) Postdoctoral FellowshipCTSI
    Mount Sinai HospitalInternal Medicine (ABIM Research Pathway)2013Medicine
    SUNY BuffaloM.D.2011School of Medicine
    UCSDB.S.2005Biochemistry/Chemistry

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wei XX, Hsieh AC, Kim W, Friedlander T, Lin AM, Louttit M, Ryan CJ. A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer. Oncologist. 2017 Mar 17. PMID: 28314838.
      View in: PubMed
    2. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 Sep 29. PMID: 27688020.
      View in: PubMed
    3. Wei X, Fong L, Small EJ. Prospects for the use of ipilimumab in treating advanced prostate cancer. Expert Opin Biol Ther. 2016 Mar; 16(3):421-32. PMID: 26698365.
      View in: PubMed
    4. Majd N, Wei X, Demopoulos A, Hormigo A, Chari A. Characterization of central nervous system multiple myeloma in the era of novel therapies. Leuk Lymphoma. 2016 Jul; 57(7):1709-13. PMID: 26727654.
      View in: PubMed
    5. Wei XX, Fong L, Small EJ. Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions. Expert Rev Vaccines. 2015 Dec; 14(12):1529-41. PMID: 26488270.
      View in: PubMed
    6. Xu H, Cheung IY, Wei XX, Tran H, Gao X, Cheung NK. Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma. Int J Cancer. 2011 Oct 15; 129(8):1953-62. PMID: 21154747.
      View in: PubMed
    7. Cai H, Babic I, Wei X, Huang J, Witte ON. Invasive prostate carcinoma driven by c-Src and androgen receptor synergy. Cancer Res. 2011 Feb 1; 71(3):862-72. PMID: 21135112; PMCID: PMC3032821.
    8. Nair-Gill E, Wiltzius SM, Wei XX, Cheng D, Riedinger M, Radu CG, Witte ON. PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice. J Clin Invest. 2010 Jun; 120(6):2005-15. PMID: 20484820; PMCID: PMC2877561.
    9. Smolka MB, Chen SH, Maddox PS, Enserink JM, Albuquerque CP, Wei XX, Desai A, Kolodner RD, Zhou H. An FHA domain-mediated protein interaction network of Rad53 reveals its role in polarized cell growth. J Cell Biol. 2006 Dec 4; 175(5):743-53. PMID: 17130285; PMCID: PMC2064674.
    10. Smolka MB, Albuquerque CP, Chen SH, Schmidt KH, Wei XX, Kolodner RD, Zhou H. Dynamic changes in protein-protein interaction and protein phosphorylation probed with amine-reactive isotope tag. Mol Cell Proteomics. 2005 Sep; 4(9):1358-69. PMID: 15972895; PMCID: PMC2813687.
    Xiao's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP